91ɫƵ

header-logo
headshot

Srividya Kidambi, MD, MS

Chief, Professor

Locations

  • Froedtert Hospital
  • Endocrinology - Froedtert Hospital

Specialties

  • Endocrinology

Languages

  • English, Hindi

New & Established Patients Call

Education

  • MD - Doctor of Medicine
  • MS -Master of Science

Biography

Dr. Kidambi is a professor and chief of the Division of Endocrinology and Molecular Medicine at the 91ɫƵ/Froedtert Hospital. Dr. Kidambi received her Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College, Hyderabad, Andhra Pradesh, India. She completed her residency at the State University of New York at Buffalo. She completed her fellowship in Endocrinology and Master of Science in Epidemiology at the 91ɫƵ. She joined the 91ɫƵ in 2008.

Leadership Positions

91ɫƵ Internal

  • Co-Director, 91ɫƵ Medical Weight Loss and Bariatric Surgery Program

Research Interests

Dr. Kidambi is intensely passionate about chronic disease states that are associated with metabolic syndrome and cardiovascular disease. Her main focus is providing care to patients with diabetes and obesity. In addition, after having conducted research on high blood pressure for several years, her expertise is in high blood pressure management, particularly high blood pressure in young patients, drug-resistant hypertension, and hypertension secondary to hormonal disorders. Furthermore, she also takes care of patients with polycystic ovarian disease.

Care Emphasis:

- Diabetic mellitus
- Obesity
- Metabolic Syndrome
- Drug-resistant hypertension
- High blood pressure due to hormonal disorders
- Primary hyperaldosteronism
- Adrenal disorders
- Polycystic ovarian disease

Dr. Kidambi says, "My goal is to make patients comfortable enough to share their story with me. I believe that disease is just one aspect of a patient's life and there are other things in their lives that can impact their disease and its treatment. I have a passion to treat chronic diseases and spend a lot of time trying to understand the things that motivate patients who struggle with diseases which do not have an easy solution. My reward is change in their outlook and improvement in their health."

Research Interests

The role of body fat distribution in obesity related diseases

Obesity prevalence is increasing and is associated with significant harmful consequences on one's health. Our research is aimed at understanding why some obese adults remain healthy while others develop diseases such as diabetes or heart disease. Previous studies suggest that it may be the way the fat is distributed in our body. For example, some have fat mainly in the stomach area (apple-shaped) while other have fat distributed equally throughout the body but more so in the buttock and thigh areas (pear-shaped). Studies have suggested that those who have fat distributed in a pear-shaped fashion may be protected from negative effects of excess body weight. Fat distributed in the periphery may be a source of cellular factors that protect some subjects from negative effects of obesity.

In collaboration with a number of investigators, Dr. Kidambi and her team is currently studying the role of different fat depots on heart health and diabetes.

Publications

  • (Pan X, Chen Y, Yang Y, Kidambi S, Liang M, Liu P.) J Hypertens. 2024 Oct 01;42(10):1750-1756 PMID: 38973536 PMCID: PMC11361834 SCOPUS ID: 2-s2.0-85198263573 07/08/2024

  • (Wildes MP, Fernando DG, Grobe CC, Reho JJ, Grobe JL, Kidambi S, Kindel TL, Kwitek AE, Segar JL, Williams JS, Morselli LL.) Endocrinology. 2024 Aug 27;165(10) PMID: 39236000 PMCID: PMC11408931 SCOPUS ID: 2-s2.0-85204510410 09/05/2024

  • (Lee JY, Mullis DM, Zawadzki RS, Nilkant R, Kuhan S, Kidambi S, Sharir A, Ma M.) Pediatr Transplant. 2024 Aug;28(5):e14807 PMID: 38923151 06/26/2024

  • (Morselli LL, Amjad R, James R, Kindel TL, Kwitek AE, Williams JS, Grobe JL, Kidambi S.) J Endocr Soc. 2024 Apr 06;8(6):bvae062 PMID: 38623381 PMCID: PMC11017326 SCOPUS ID: 2-s2.0-85190716270 04/16/2024

  • (Bybee G, Moeun Y, Wang W, Kharbanda KK, Poluektova LY, Kidambi S, Osna NA, Ganesan M.) Front Immunol. 2023;14:1166171 PMID: 37600826 PMCID: PMC10435739 08/21/2023

  • (DeLozier OM, Dream S, Findling JW, Rilling W, Kidambi S, Magill SB, Evans DB, Wang TS.) J Surg Res. 2022 Sep;277:1-6 PMID: 35453052 SCOPUS ID: 2-s2.0-85128261569 04/23/2022

  • (Roberts ML, Kotchen T, Pan X, Li Y, Yang C, Liu P, Wang T, Laud P, Chelius TH, Munyura Y, Mattson DL, Liu Y, Cowley AW Jr, Kidambi S, Liang M.) FASEB J. 2022 May;36 Suppl 1 PMID: 35554876 SCOPUS ID: 2-s2.0-85130064478 05/14/2022

  • (Roberts ML, Kotchen TA, Pan X, Li Y, Yang C, Liu P, Wang T, Laud PW, Chelius TH, Munyura Y, Mattson DL, Liu Y, Cowley AW Jr, Kidambi S, Liang M.) Hypertension. 2022 Apr;79(4):761-772 PMID: 34994206 PMCID: PMC8917053 SCOPUS ID: 2-s2.0-85126152389 01/08/2022

  • (Semova I, Levenson AE, Krawczyk J, Bullock K, Gearing ME, Ling AV, Williams KA, Miao J, Adamson SS, Shin DJ, Chahar S, Graham MJ, Crooke RM, Hagey LR, Vicent D, de Ferranti SD, Kidambi S, Clish CB, Biddinger SB.) Circulation. 2022 Mar 29;145(13):969-982 PMID: 35193378 PMCID: PMC9365453 SCOPUS ID: 2-s2.0-85127325466 02/24/2022

  • (Dream S, Park S, Yen TW, Rilling W, Rein L, Doffek K, Findling JW, Magill SB, Kidambi S, Evans DB, Wang TS.) Endocr Pract. 2022 Mar;28(3):276-281 PMID: 34582994 SCOPUS ID: 2-s2.0-85125481960 09/29/2021

  • (Cowley AW Jr, Kidambi S, Liang M, Grim C, Hamet P.) Hypertension. 2021 Dec;78(6):1674-1676 PMID: 34719936 SCOPUS ID: 2-s2.0-85121955751 11/02/2021

  • (Batsis JA, Apolzan JW, Bagley PJ, Blunt HB, Divan V, Gill S, Golden A, Gundumraj S, Heymsfield SB, Kahan S, Kopatsis K, Port A, Parks EP, Reilly CA, Rubino D, Saunders KH, Shean R, Tabaza L, Stanley A, Tchang BG, Gundumraj S, Kidambi S.) Obesity. July 2021;29(7):1102-1113 SCOPUS ID: 2-s2.0-85108382801 07/01/2021